The value of high-dose radiotherapy in intracranial ependymoma.
Bryan J AgerMichael T ChristensenLindsay M BurtMatthew M PoppePublished in: Pediatric blood & cancer (2019)
Adjuvant radiotherapy dose > 5400 cGy was associated with improved OS for children aged 2-18 years with WHO grade II-III intracranial ependymoma. No OS benefit was found with > 5400 cGy in adults or children less than two years of age.